Veneno Technologies Co.
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $1.7M
Investors
- 3
About Veneno Technologies Co.
, Ltd. creates therapeutic disulfide-rich peptides targeting drug target transmembrane proteins which includes ion channels, transporters, and GPCRs., Ltd. has also developed technologies that enable the practical application of DRP molecules, and PERISS (Intra Periplasm Secretion and Selection). DRPs are considered to be the next-generation modality for drug discovery and development. DRPs have a unique knot structure with multiple disulfide bonds in the molecule. Due to the rigidity of such a framework, DRPs are highly stable to pH, heat, and enzymes, especially in comparison with linear peptides. Similar to venoms, DRPs are bioactive peptides with high potency and selectivity. PERISS is a new screening method based on evolutionary molecular engineering. In the PERISS cycle, the DRP genetic variants undergo molecular selection by phenotype, and by repeating this cycle, the target DRP candidate can be efficiently obtained within a short time.
Who invested in Veneno Technologies Co.
3 investors across 1 round
See all investors in Veneno Technologies Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 24, 2022
Amount
$1.7M
Investors
Questions about Veneno Technologies Co.
Who invested in Veneno Technologies Co.?
Veneno Technologies Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veneno Technologies Co. raised?
Veneno Technologies Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Veneno Technologies Co. last raise money?
Veneno Technologies Co.'s most recent round on record is a Series A, in Jan 2022.
What does Veneno Technologies Co. do?
Veneno Technologies Co. is a biotechnology company.
Where is Veneno Technologies Co. headquartered?
Veneno Technologies Co. is headquartered in Tsukuba-shi, Japan.
Which VCs invest in companies like Veneno Technologies Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Veneno Technologies Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Veneno Technologies Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.